Search Results - "HONKO, Anna"
-
1
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study
Published in The Lancet infectious diseases (01-08-2015)“…Summary Background The limited data available for long-term Ebola virus disease health outcomes suggest that sequelae persist for longer than 1 year after…”
Get full text
Journal Article -
2
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Published in The Lancet (British edition) (29-05-2010)“…Summary Background We previously showed that small interfering RNAs (siRNAs) targeting the Zaire Ebola virus (ZEBOV) RNA polymerase L protein formulated in…”
Get full text
Journal Article -
3
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
Published in Cell (16-09-2021)“…Memory B cell reserves can generate protective antibodies against repeated SARS-CoV-2 infections, but with unknown reach from original infection to…”
Get full text
Journal Article -
4
Optimized microRNA purification from TRIzol-treated plasma
Published in BMC genomics (18-02-2015)“…MicroRNAs (miRNAs) represent new and potentially informative diagnostic targets for disease detection and prognosis. However, little work exists documenting…”
Get full text
Journal Article -
5
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
Published in Nature medicine (01-10-2014)“…A chimpanzee adenovirus-based vaccination approach elicits acute and long-term protection against ebolavirus challenge in nonhuman primates. Ebolavirus disease…”
Get full text
Journal Article -
6
Detailed analysis of the pathologic hallmarks of Nipah virus (Malaysia) disease in the African green monkey infected by the intratracheal route
Published in PloS one (10-02-2022)“…Disease associated with Nipah virus infection causes a devastating and often fatal spectrum of syndromes predominated by both respiratory and neurologic…”
Get full text
Journal Article -
7
Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs
Published in PloS one (22-03-2018)“…Identifying effective antivirals for treating Ebola virus disease (EVD) and minimizing transmission of such disease is critical. A variety of cell-based assays…”
Get full text
Journal Article -
8
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies
Published in PLoS pathogens (11-04-2024)“…Monoclonal antibodies (mAbs) are an important class of antiviral therapeutics. MAbs are highly selective, well tolerated, and have long in vivo half-life as…”
Get full text
Journal Article -
9
Detailed analysis of the African green monkey model of Nipah virus disease
Published in PloS one (23-02-2015)“…Henipaviruses are implicated in severe and frequently fatal pneumonia and encephalitis in humans. There are no approved vaccines or treatments available for…”
Get full text
Journal Article -
10
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species
Published in PLoS pathogens (01-05-2010)“…A major challenge in developing vaccines for emerging pathogens is their continued evolution and ability to escape human immunity. Therefore, an important goal…”
Get full text
Journal Article -
11
In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
Published in BMC genomics (05-09-2016)“…Ebola virus is the causative agent of a severe syndrome in humans with a fatality rate that can approach 90 %. During infection, the host immune response is…”
Get full text
Journal Article -
12
broad-spectrum antiviral targeting entry of enveloped viruses
Published in Proceedings of the National Academy of Sciences - PNAS (16-02-2010)“…We describe an antiviral small molecule, LJ001, effective against numerous enveloped viruses including Influenza A, filoviruses, poxviruses, arenaviruses,…”
Get full text
Journal Article -
13
Monoclonal antibody therapy for Junin virus infection
Published in Proceedings of the National Academy of Sciences - PNAS (19-04-2016)“…Countermeasures against potential biothreat agents remain important to US Homeland Security, and many of these pharmaceuticals could have dual use in the…”
Get full text
Journal Article -
14
Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells
Published in Antiviral research (01-07-2014)“…•Pyridinyl imidazole inhibitors of p38 MAP kinases inhibit ebolavirus replication in macrophages and dendritic cells.•Pyridinyl imidazole inhibitors of p38 MAP…”
Get full text
Journal Article -
15
Low-Input, High-Resolution 5' Terminal Filovirus RNA Sequencing with ViBE-Seq
Published in Viruses (01-07-2024)“…Although next-generation sequencing (NGS) has been instrumental in determining the genomic sequences of emerging RNA viruses, de novo sequence determination…”
Get full text
Journal Article -
16
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
Published in Science translational medicine (14-12-2022)“…Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality rates in humans of up to 90%. MARV has been identified as a category…”
Get more information
Journal Article -
17
Development and evaluation of a panel of filovirus sequence capture probes for pathogen detection by next-generation sequencing
Published in PloS one (10-09-2014)“…A detailed understanding of the circulating pathogens in a particular geographic location aids in effectively utilizing targeted, rapid diagnostic assays, thus…”
Get full text
Journal Article -
18
Flagellin Is an Effective Adjuvant for Immunization against Lethal Respiratory Challenge with Yersinia pestis
Published in Infection and Immunity (01-02-2006)“…Gram-negative flagellin, a Toll-like receptor 5 (TLR5) agonist, is a potent inducer of innate immune effectors such as cytokines and nitric oxide. In the lung,…”
Get full text
Journal Article -
19
Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival
Published in Clinical infectious diseases (23-03-2022)“…Abstract The clinical significance of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) RNA in stool remains uncertain. We found that extrapulmonary…”
Get full text
Journal Article -
20
Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
Published in Journal of Virology (01-05-2011)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article